CIK: 0001595851 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value: $461M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 500,000 | $226M | 49.0% | $451.64 | — | — | Put | 78462F103 |
| XBI | SPDR SER TR | 300,000 | $26.96M | 5.9% | $89.88 | — | — | Call | 78464A870 |
| ASND | ASCENDIS PHARMA A/S | 140,000 | $16.43M | 3.6% | $117.36 | $131.68 | — | SPONSORED ADR | 04351P101 |
| COGT | COGENT BIOSCIENCES INC | 1,700,000 | $12.73M | 2.8% | $7.49 * | $10.34 | -32.7% | COM | 19240Q201 |
| APLS | APELLIS PHARMACEUTICALS INC | 250,000 | $12.7M | 2.8% | $50.81 * | $49.72 | -11.2% | COM | 03753U106 |
| — | MERUS N V | 400,000 | $10.58M | 2.3% | $26.44 | $29.12 | — | COM | N5749R100 |
| FOLD | AMICUS THERAPEUTICS INC | 1,100,000 | $10.42M | 2.3% | $9.47 | $11.01 | -14.8% | COM | 03152W109 |
| — | SIERRA ONCOLOGY INC | 325,000 | $10.42M | 2.3% | $32.05 | $20.61 | — | COM NEW | 82640U404 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 300,000 | $10.22M | 2.2% | $34.06 * | $28.96 | +10.4% | COM NEW | 15117B202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 466,403 | $8.624M | 1.9% | $18.49 * | $18.53 | +3.7% | COM | 92790C104 |
| — | KARUNA THERAPEUTICS INC | 60,000 | $7.607M | 1.7% | $126.78 | $126.78 | — | COM | 48576A100 |
| — | IVERIC BIO INC | 450,000 | $7.574M | 1.6% | $16.83 | $7.44 | — | COM | 46583P102 |
| ARVN | ARVINAS INC | 110,000 | $7.403M | 1.6% | $67.30 | $28.07 | +142.8% | COM | 04335A105 |
| PCVX | VAXCYTE INC | 300,000 | $7.245M | 1.6% | $24.15 * | $21.73 | +0.6% | COM | 92243G108 |
| — | KEZAR LIFE SCIENCES INC | 400,000 | $6.648M | 1.4% | $16.62 | $16.68 | — | COM | 49372L100 |
| AXSM | AXSOME THERAPEUTICS INC | 150,000 | $6.209M | 1.3% | $41.39 * | $31.00 | 0.0% | Put | 05464T104 |
| — | CTI BIOPHARMA CORP | 1,300,000 | $6.071M | 1.3% | $4.67 | $2.98 | — | COM | 12648L601 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 350,000 | $5.691M | 1.2% | $16.26 | $16.04 | 0.0% | COM | 09058V103 |
| — | RAPT THERAPEUTICS INC | 250,000 | $5.498M | 1.2% | $21.99 | $33.20 | — | COM | 75382E109 |
| BCYC | BICYCLE THERAPEUTICS PLC | 100,000 | $4.388M | 1.0% | $43.88 | $43.88 | — | SPONSORED ADS | 088786108 |
| AXSM | AXSOME THERAPEUTICS INC | 94,500 | $3.911M | 0.8% | $41.39 * | $31.00 | 0.0% | COM | 05464T104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 225,000 | $3.911M | 0.8% | $17.38 * | $18.21 | -7.5% | COM | 87164F105 |
| SRPT | SAREPTA THERAPEUTICS INC | 50,000 | $3.906M | 0.8% | $78.12 | $85.49 | -10.4% | COM | 803607100 |
| — | VERONA PHARMA PLC | 750,000 | $3.743M | 0.8% | $4.99 | $6.53 | — | SPONSORED ADS | 925050106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 80,000 | $3.691M | 0.8% | $46.14 * | $61.38 | -12.1% | COM | 98943L107 |
| DSGN | DESIGN THERAPEUTICS INC | 200,000 | $3.23M | 0.7% | $16.15 * | $16.57 | -7.5% | COM | 25056L103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 200,000 | $3.172M | 0.7% | $15.86 * | $29.94 | -42.3% | COM | 77313F106 |
| XENE | XENON PHARMACEUTICALS INC | 100,000 | $3.057M | 0.7% | $30.57 * | $13.60 | +120.1% | COM | 98420N105 |
| RLMD | RELMADA THERAPEUTICS INC | 100,000 | $2.699M | 0.6% | $26.99 * | $26.77 | -22.7% | COM | 75955J402 |
| WHWK | AADI BIOSCIENCE INC | 150,000 | $2.546M | 0.6% | $16.97 * | $25.11 | -23.7% | COM | 00032Q104 |
| ACRS | ACLARIS THERAPEUTICS INC | 125,000 | $2.155M | 0.5% | $17.24 * | $6.81 | +100.4% | COM | 00461U105 |
| TARS | TARSUS PHARMACEUTICALS INC | 120,000 | $2.018M | 0.4% | $16.82 * | $31.23 | -40.6% | COM | 87650L103 |
| — | 9 METERS BIOPHARMA INC | 3,250,000 | $1.948M | 0.4% | $0.60 | $1.25 | — | COM | 654405109 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 85,000 | $1.866M | 0.4% | $21.95 * | $17.57 | +15.2% | COM | 22663K107 |
| — | SATSUMA PHARMACEUTICALS INC | 473,562 | $1.8M | 0.4% | $3.80 | $10.24 | — | COM | 80405P107 |
| — | LEAP THERAPEUTICS INC | 993,714 | $1.739M | 0.4% | $1.75 | $4.01 | — | COM | 52187K101 |
| — | MIRATI THERAPEUTICS INC | 20,000 | $1.644M | 0.4% | $82.20 | $98.34 | — | COM | 60468T105 |
| — | VISTAGEN THERAPEUTICS INC | 1,315,154 | $1.631M | 0.4% | $1.24 | $2.02 | — | COM NEW | 92840H202 |
| — | AEGLEA BIOTHERAPEUTICS INC | 686,599 | $1.579M | 0.3% | $2.30 | $2.30 | — | COM | 00773J103 |
| — | PARDES BIOSCIENCES INC | 85,000 | $614K | 0.1% | $7.22 | $12.61 | — | COM | 69945Q105 |
| LRMR | LARIMAR THERAPEUTICS INC | 100,000 | $405K | 0.1% | $4.05 * | $11.59 | -43.5% | COM | 517125100 |
| PYXS | PYXIS ONCOLOGY INC | 75,000 | $303K | 0.1% | $4.04 * | $11.45 | -36.2% | COMMON STOCK | 747324101 |